Table of contents

• 1) Authorship
• 2) Originality, Plagiarism, and Duplicate Publication
• 3) Secondary Publication
• 4) Conflict-of-Interest Statement
• 5) Statement of Human and Animal Right
• 6) Statement of Informed Consent and Institutional Review Board Approval
• 7) Registration of the Clinical Trial Research
• 8) Process for Managing Research and Publication Misconduct
• 9) Process for Handling Cases Requiring Corrections, Retractions, and Editorial Expressions of Concern
• 10) Editorial Responsibilities

For the policies on the research and publication ethics not stated in this site, Good Publication Practice Guidelines for Medical Journals (https://www.ismpp.org/gpp3) or Guidelines on Good Publication (https://publicationethics.org/) can be applied.

1) Authorship

A. Authorship credit should be based on the recommendation of the International Committee of Medical Journal Editors (ICMJE)

• (1) Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; AND
• (2) Drafting the work or revising it critically for important intellectual content; AND
• (3) Final approval of the version to be published; AND
• (4) Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Every author should meet all these four conditions.

B. After the initial submission of a manuscript, any changes whatsoever in authorship (adding author(s), deleting author(s), or re-arranging the order of authors) must be explained by a letter to the editor from the authors concerned. This letter must be signed by all authors of the paper. Copyright assignment must also be completed by every author.

C. Correction of authorship:Korean Journal of Head & Neck Oncology does not correct authorship after publication unless a mistake has been made by the editorial staff. Authorship may be changed before publication but after submission when an authorship correction is requested by all of the authors involved with the manuscript.

2) Originality, Plagiarism, and Duplicate Publication

A. Submitted manuscripts must not have been previously published or be under consideration for publication elsewhere. No part of the accepted manuscript should be duplicated in any other scientific journal without the permission of the Editorial Board. This restriction does not apply to abstracts or press reports published in connection with scientific meetings.

B. Submitted manuscripts are screened for possible plagiarism or duplicate publication by Similarity Check upon arrival. If plagiarism or duplicate publication related to the papers of this journal is detected, the manuscripts may be rejected, the authors will be announced in the journal, and their institutions will be informed. There will also be penalties for the authors.

C. A letter of permission is required for any and all material that has been published previously. It is the responsibility of the author to request permission from the publisher for any material that is being reproduced. This requirement applies to text, figures, and tables.

3) Secondary Publication

It is possible to republish manuscripts if the manuscripts satisfy the conditions of secondary publication of the ICMJE Recommendations.

4) Conflict-of-Interest Statement

A conflict of interest may exist when an author (or the author’s institution or employer) has financial or personal relationships that could inappropriately influence (or bias) the author’s decisions, work, or manuscript. Potential conflict of interest is applied even when the authors are confident that their judgments have not been influenced in the manuscript. Such conflicts may be financial supports or connections to pharmaceutical companies, political pressure from interest groups, or academic problems. The Editor-in-Chief will decide whether the information of the conflict should be included in the published paper. Before publishing such information, the Editor-in-Chief will consult with the corresponding author. In particular, all sources of funding for a research should be explicitly stated.

5) Statement of Human and Animal Right

Clinical research should be done in accordance of the Ethical Principles for Medical Research Involving Human Subjects, outlined in the Helsinki Declaration. Clinical studies that do not meet the Helsinki Declaration will not be considered for publication. Human subjects should not be identifiable, such that patients' names, initials, hospital numbers, dates of birth, or other protected healthcare information should not be disclosed. For animal subjects, research should be performed based on the National or Institutional Guide for the Care and Use of Laboratory Animals, and the ethical treatment of all experimental animals should be maintained.

6) Statement of Informed Consent and Institutional Review Board Approval

Copies of written informed consents should be kept for studies on human subjects. For the clinical studies with human subjects, there should be a certificate, an agreement, or the approval by the Institutional Review Board (IRB) of the author's affiliated institution. If necessary, the editor or reviewers may request copies of these documents to resolve questions about IRB approval and study conduct.

7) Registration of the Clinical Trial Research

Any research that deals with a clinical trial should be registered with the primary national clinical trial registry site such as the Korea Clinical Research Information Service (CRiS), other primary national registry sites accredited by the World Health Organization, or ClinicalTrials.gov, a service of the United States National Institutes of Health.

8) Process for Managing Research and Publication Misconduct

When the journal faces suspected cases of research and publication misconduct such as redundant (duplicate) publication, plagiarism, fraudulent or fabricated data, changes in authorship, an undisclosed conflict of interest, ethical problems with a submitted manuscript, a reviewer who has appropriated an author’s idea or data, complaints against editors, and so on, the resolution process will follow the flowchart provided by the Committee on Publication Ethics. The discussion and decision on the suspected cases are carried out by the Editorial Board.

9) Process for Handling Cases Requiring Corrections, Retractions, and Editorial Expressions of Concern

Cases that require editorial expressions of concern or retraction shall follow the COPE flowcharts available from: http://publicationethics.org/resources/flowcharts. If correction needs, it will follow the ICMJE Recommendation for Corrections, Retractions, Republications and Version Control.

10) Editorial Responsibilities

The Editorial Board will continuously work to monitor and safeguard publication ethics: guidelines for retracting articles; maintenance of the integrity of the academic record; preclusion of business needs from compromising intellectual and ethical standards; publishing corrections, clarifications, retractions, and apologies when needed; and excluding plagiarism and fraudulent data. The editors maintain the following responsibilities: responsibility and authority to reject and accept articles; avoiding any conflict of interest with respect to articles they reject or accept; promoting publication of corrections or retractions when errors are found; and preservation of the anonymity of reviewers.